Article

AUA symposium images

images

Related Videos
Human kidney stones | Image Credit: © freshidea - stock.adobe.com
Pain management disparities in kidney stones point to need for guidelines, experts say
John Taylor, III, MD, on novel options in NMIBC
John Taylor, III, MD, on novel options in NMIBC
Man talking with doctor | Image Credit: © RFBSIP - stock.adobe.com
FDA testosterone labeling changes: How will they affect prescribing?
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Why a personalized approach is key to prolapse and OAB management
Timothy Lyon, MD, highlights study assessing accuracy of urology rankings
Timothy Lyon, MD, highlights study assessing accuracy of urology rankings
Suzanne B. Merrill, MD, FACS, answers a question during a Zoom video interview
Suzanne B. Merrill, MD, FACS, on EAP program for recombinant BCG
Addressing Remaining Unmet Needs in mCRPC
Addressing Remaining Unmet Needs in mCRPC
Use and Sequencing of Novel Treatments in NMIBC
Use and Sequencing of Novel Treatments in NMIBC
The DORA Trial
The DORA Trial
FDA-Approved Treatments for BCG-Unresponsive NMIBC
FDA-Approved Treatments for BCG-Unresponsive NMIBC
Related Content
FDA approves durvalumab/chemo for muscle–invasive bladder cancer
March 28th 2025

FDA approves durvalumab/chemo for muscle–invasive bladder cancer

Hannah Clarke
The approval is supported by results from the phase 3 NIAGARA trial.
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
FDA grants marketing authorization to at-home diagnostic test for STIs
March 28th 2025

FDA grants marketing authorization to at-home diagnostic test for STIs

Hannah Clarke
The test can deliver diagnostic results for chlamydia, gonorrhea, and trichomoniasis.
Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
February 21st 2025

Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Study finds geographic disparities in MRI use in prostate cancer
March 27th 2025

Study finds geographic disparities in MRI use in prostate cancer

Hannah Clarke
The use of pre-diagnostic MRI was 3.8% in 2012, which increased to 32.6% in 2019.
RAG-01 elicits complete responses in NMIBC
March 26th 2025

RAG-01 elicits complete responses in NMIBC

Hannah Clarke
"The striking CR rates observed in these early cohorts are highly encouraging, particularly for BCG-unresponsive NMIBC patients who currently have limited treatment options," says Paul D. Anderson, MBBS, FRACS.
© 2025 MJH Life Sciences

All rights reserved.